Brunk et al., 2018 - Google Patents
Recon3D enables a three-dimensional view of gene variation in human metabolismBrunk et al., 2018
View HTML- Document ID
- 12988370306102310352
- Author
- Brunk E
- Sahoo S
- Zielinski D
- Altunkaya A
- Dräger A
- Mih N
- Gatto F
- Nilsson A
- Preciat Gonzalez G
- Aurich M
- Prlić A
- Sastry A
- Danielsdottir A
- Heinken A
- Noronha A
- Rose P
- Burley S
- Fleming R
- Nielsen J
- Thiele I
- Palsson B
- Publication year
- Publication venue
- Nature biotechnology
External Links
Snippet
Genome-scale network reconstructions have helped uncover the molecular basis of metabolism. Here we present Recon3D, a computational resource that includes three- dimensional (3D) metabolite and protein structure data and enables integrated analyses of …
- 230000036740 Metabolism 0 title abstract description 36
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/18—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for functional genomics or proteomics, e.g. genotype-phenotype associations, linkage disequilibrium, population genetics, binding site identification, mutagenesis, genotyping or genome annotation, protein-protein interactions or protein-nucleic acid interactions
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/12—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for modelling or simulation in systems biology, e.g. probabilistic or dynamic models, gene-regulatory networks, protein interaction networks or metabolic networks
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/16—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for molecular structure, e.g. structure alignment, structural or functional relations, protein folding, domain topologies, drug targeting using structure data, involving two-dimensional or three-dimensional structures
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/24—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for machine learning, data mining or biostatistics, e.g. pattern finding, knowledge discovery, rule extraction, correlation, clustering or classification
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
- G06F19/322—Management of patient personal data, e.g. patient records, conversion of records or privacy aspects
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/22—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for sequence comparison involving nucleotides or amino acids, e.g. homology search, motif or SNP [Single-Nucleotide Polymorphism] discovery or sequence alignment
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/70—Chemoinformatics, i.e. data processing methods or systems for the retrieval, analysis, visualisation, or storage of physicochemical or structural data of chemical compounds
- G06F19/706—Chemoinformatics, i.e. data processing methods or systems for the retrieval, analysis, visualisation, or storage of physicochemical or structural data of chemical compounds for drug design with the emphasis on a therapeutic agent, e.g. ligand-biological target interactions, pharmacophore generation
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/20—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for hybridisation or gene expression, e.g. microarrays, sequencing by hybridisation, normalisation, profiling, noise correction models, expression ratio estimation, probe design or probe optimisation
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/26—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for data visualisation, e.g. graphics generation, display of maps or networks or other visual representations
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
- G06F17/20—Handling natural language data
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
- G06F17/30—Information retrieval; Database structures therefor; File system structures therefor
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Brunk et al. | Recon3D enables a three-dimensional view of gene variation in human metabolism | |
Chen et al. | Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases | |
Zhang et al. | MutaBind2: predicting the impacts of single and multiple mutations on protein-protein interactions | |
Tunyasuvunakool et al. | Highly accurate protein structure prediction for the human proteome | |
Zhou et al. | Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents | |
Matreyek et al. | Multiplex assessment of protein variant abundance by massively parallel sequencing | |
Blais et al. | Reconciled rat and human metabolic networks for comparative toxicogenomics and biomarker predictions | |
IMEx Consortium Curators Khadake J. IntAct team: 1 The IMEx Consortium Curators Meldal B. 1 The IMEx Consortium Curators Panni S. 8 The IMEx Consortium Curators Thorneycroft D. 1 The IMEx Consortium Curators van Roey K. 1 The IMEx Consortium Curators Abbani S. DIP team: 9 The IMEx Consortium Curators Salwinski L. 9 The IMEx Consortium Curators Pellegrini M. 9 The IMEx Consortium Curators Iannuccelli M. MINT team: 10 The IMEx Consortium Curators Licata L. 10 The IMEx Consortium Curators Cesareni G. 10 The IMEx Consortium Curators Roechert B. SwissProt-UniProt team: 11 The IMEx Consortium Curators Bridge A. 11 The IMEx Consortium Curators Ammari MG HPIDb team: 12 The IMEx Consortium Curators McCarthy F. 12 The IMEx Consortium Curators Broackes-Carter F. I2D team: 5 The IMEx Consortium Curators Campbell NH BHF-UCL team: 13 The IMEx Consortium Curators Melidoni AN 1 13 The IMEx Consortium Curators Rodriguez-Lopez M. 1 13 The IMEx Consortium Curators Lovering RC 13 The IMEx Consortium Curators Jagannathan S. MBInfo team: 14 The IMEx Consortium Curators Chen C. InnateDB team: 15 The IMEx Consortium Curators Lynn DJ 16 17 The IMEx Consortium Curators Ricard-Blum S. MatrixDB team: 18 The IMEx Consortium Curators Mahadevan U. Molecular Connections team: 19 The IMEx Consortium Curators Raghunath A. 19 The IMEx Consortium Curators et al. | Capturing variation impact on molecular interactions in the IMEx Consortium mutations data set | |
Costello et al. | A community effort to assess and improve drug sensitivity prediction algorithms | |
Roy et al. | I-TASSER: a unified platform for automated protein structure and function prediction | |
Wang et al. | Insights into the mutation-induced HHH syndrome from modeling human mitochondrial ornithine transporter-1 | |
Zielinski et al. | Pharmacogenomic and clinical data link non-pharmacokinetic metabolic dysregulation to drug side effect pathogenesis | |
Zhang et al. | Proteomics is not an island: multi-omics integration is the key to understanding biological systems | |
Liao et al. | In silico methods for identification of potential active sites of therapeutic targets | |
Hebestreit et al. | Leukemia gene atlas–a public platform for integrative exploration of genome-wide molecular data | |
Vidal et al. | The human proteome–a scientific opportunity for transforming diagnostics, therapeutics, and healthcare | |
Robertson et al. | Expanding the druggable space of the LSD1/CoREST epigenetic target: new potential binding regions for drug-like molecules, peptides, protein partners, and chromatin | |
Xu et al. | Predicting inactive conformations of protein kinases using active structures: conformational selection of type-II inhibitors | |
Borgio et al. | Mutation near the binding interfaces at α-hemoglobin stabilizing protein is highly pathogenic | |
Vieira et al. | A pipeline for the reconstruction and evaluation of context-specific human metabolic models at a large-scale | |
Martínez-Jiménez et al. | Ligand-target prediction by structural network biology using nAnnoLyze | |
Litsa et al. | Machine learning guided atom mapping of metabolic reactions | |
Rogers et al. | SARS-CoV2 billion-compound docking | |
Mueller et al. | BALL-SNP: combining genetic and structural information to identify candidate non-synonymous single nucleotide polymorphisms | |
Granados et al. | Regulation of human endogenous metabolites by drug transporters and drug metabolizing enzymes: an analysis of targeted SNP-metabolite associations |